Jiangsu Nanfang Medical (603880) — Cash Flow-to-Debt Ratio
Jiangsu Nanfang Medical (603880) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥12.53 Million could theoretically repay 0% of its total liabilities (CN¥733.89 Million) in one year. See Jiangsu Nanfang Medical leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Nanfang Medical Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Jiangsu Nanfang Medical across 14 annual periods. For the full cash flow conversion analysis, see Jiangsu Nanfang Medical operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Jiangsu Nanfang Medical (2012–2025)
Year-by-year debt coverage analysis for Jiangsu Nanfang Medical. Check Jiangsu Nanfang Medical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥47.73 Million | CN¥746.77 Million | ▼ -22.1% |
| 2024 | 0.08x | CN¥63.32 Million | CN¥772.14 Million | ▲ +324.6% |
| 2023 | 0.02x | CN¥15.51 Million | CN¥803.11 Million | ▼ -48.4% |
| 2022 | 0.04x | CN¥31.28 Million | CN¥835.75 Million | ▲ +125.8% |
| 2021 | -0.15x | CN¥-84.25 Million | CN¥580.29 Million | ▼ -135.0% |
| 2020 | 0.41x | CN¥154.12 Million | CN¥371.84 Million | ▲ +279.5% |
| 2019 | 0.11x | CN¥32.99 Million | CN¥302.08 Million | ▼ -40.8% |
| 2018 | 0.18x | CN¥52.75 Million | CN¥285.78 Million | ▲ +7.0% |
| 2017 | 0.17x | CN¥49.24 Million | CN¥285.40 Million | ▼ -54.9% |
| 2016 | 0.38x | CN¥99.35 Million | CN¥259.87 Million | ▲ +5.8% |
| 2015 | 0.36x | CN¥90.66 Million | CN¥250.86 Million | ▲ +11.2% |
| 2014 | 0.33x | CN¥73.52 Million | CN¥226.10 Million | ▲ +230.6% |
| 2013 | 0.10x | CN¥20.14 Million | CN¥204.78 Million | ▼ -66.6% |
| 2012 | 0.29x | CN¥76.07 Million | CN¥258.41 Million | — |